PK

Pankaj Kumar

Active Director Director DIN 09453764
DIN 09453764 First appointment Dec 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2021
Shareholding value •••• Premium profile

About Pankaj Kumar

Data last updated:

Pankaj Kumar is a Director at Medsys Pharma Private Limited (since 2021). The company operates in Chemicals. Medsys Pharma Private Limited reported revenue of ₹2,000 (FY 2024).

DIN 09453764
Primary Designation Director
Industry Chemicals
First Appointment 31 Dec 2021
Oldest Company Age 4 yrs
Largest company Medsys Pharma Private Limited · ₹2,000 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medsys Pharma Private Limited U24100UP2021PTC157572
Director31 Dec 20212021₹2,000 (FY 2024)Active

Board colleagues of Pankaj Kumar

NameDINCompanyDesignation
Ambika Devi09453763Medsys Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medsys Pharma Private Limited
Premium access

Shareholding and investment profile for Pankaj Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pankaj Kumar

Pankaj Kumar currently holds 1 directorship: Medsys Pharma Private Limited (Director, since 31 Dec 2021, revenue ₹2,000 (FY 2024)).

Pankaj Kumar was first appointed on 31 Dec 2021 as Director at Medsys Pharma Private Limited.

The current boards of Pankaj Kumar's companies include Ambika Devi (Medsys Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available